Topical application of methotrexate for inhibition of corneal angiogenesis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 237, Issue 11, 1999, Pages 920-927

  Joussen, Antonia M ^a   Kruse, Friedrich E ^b   Völcker, Hans Eberhard ^b   Kirchhof, Bernd ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FOLIC ACID ANTAGONIST; IMMUNOMODULATING AGENT; METHOTREXATE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA DISEASE; ENDOTHELIUM CELL; EYE INFLAMMATION; HUMAN; INFLAMMATORY DISEASE; MACROPHAGE; MICROSCOPY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PLASMA; PRIORITY JOURNAL; RABBIT; RHEUMATIC DISEASE; TOPICAL DRUG ADMINISTRATION; UVEITIS;

ANIMALS; AQUEOUS HUMOR; CELL DIVISION; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; OPHTHALMIC SOLUTIONS; RABBITS; TREATMENT OUTCOME;

EID: 0032842353     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050387     Document Type: Article

References (40)

1. Becker MD, Kruse FE, Joussen AM, Rohrschneider K, Nobiling R, Gebhard MM, Völcker HE (1998) In vivo fluorescence microscopy of corneal neovascularization. Graefe's Arch Clin Exp Ophthalmol 236: 390-398
2. Benelli U, Bocci G, Danesi R, Lepri A, Bernardini N, Bianchi F, Lupetti M, Dolfi A, Campagni A, Agen C, Nardi M, Del Tacca M (1998) The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. Exp Eye Res 67: 133-142
3. Bocci G, Danesi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M (1999) Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother Pharmacol 43: 205-212
4. Bjerring P, Beck HI, Zachariae H, Sogaard H (1986) Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic and histological study. Acta Derm Venerol 66: 515-519
5. Casey R, Li WW (1997) Factors controlling ocular angiogenesis. Am J Ophthalmol 124: 521-529
6. Coll-Vinent B, Cebrian M, Cid MC, Font C, Esparza J, Juan M, Yague J, Urbano-Marquez A, Grau JM (1998) Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Arthritis Rheum 41: 435-444
7. Crom WR, Evans WE (1992) Methotrexate. In: Evans WE, Schetag JJ, Jusko WJ (eds) Applied pharmacokinetics: principles of therapeutic drug monitoring. Applied Therapeutics, Vancouver, Wash, pp 29/1-29/42
8. Cronstein BN (1997). The mechanism of action of methotrexate. Rheum Dis Clin North Am 23: 739-755
9. Crum R, Szabo S, Folkman J (1985) A new class of steroids inhibits angiogenesis in the presence of heparin or heparin fragment. Science 230: 1375-1378
10. Cwikiel M, Eskilsson J, Albertsson M, Stavenow L (1996) The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture. Ann Oncol 7: 731-737
11. D'Amato RJ, Loughnan MS, Flynn E, Folkmann J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci 91: 4082-4085
12. Danesi R, Agen C, Benelli U, Paolo AD, Nardini D, Bocci G, Basolo F, Campagni A, Tacca MD (1997) Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clin Cancer Res 3: 265-272
13. DeSmet MD, Stark-Vanes V, Kohler DR, Smith J, Wittes R, Nussenblatt RB (1996) Intraocular levels of methotrexate after intravenous administration. Am J Ophthalmol 121: 442-444
14. Dev S, McCallum RM, Jaffe GJ (1999) Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 106: 111-118
15. Dolhain RJ, Tak PP, Dijkmans BA, De Kuiper P, Breedveld FC, Miltenburg AM (1998) Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br J Rheumatol 37: 502-508
16. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA (1997) Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 115: 1152-1156
17. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA (1995) Inhibition of two angiogenic pathways by distinct alpha integrins. Science 270: 1500-1502
18. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90: 2690-2694
19. Fung WE (1991) Interferon alpha-2a for treatment of ARMD. (letter) Am J Ophthalmol 112: 349-350
20. Gansauge S, Breitbart A, Rinaldi N, Schwarz-Eywill M (1997) Methotrexate in patients with moderate systemic lupus erythematosus. Ann Rheum Dis 56: 382-385
21. Hirata S, Matsubara T, Saura R, Tateishi H, Hirohata K (1989) Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum 32: 1065-1073
22. Holz FG, Krastel H, Breitbart A, Schwarz-Eywill M, Pezzutto A, Völcker HE (1992) Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids. Ger J Ophthalmol 1: 142-144
23. Kabata J, Gratwohl A, Tichelli A, John L, Speck B (1991) Hematologic values of New Zealand white rabbits determined by automated flow cytometry. Lab Anim Sci 41: 613-619
24. Katz SE, Wade NK, Anderson DP, Rootman J (1997) Anterior segment recurrence of acute myelogenous leukemia: treatment with subconjunctival injections of methotrexate and triamcinolone acetonide. Can J Ophthalmol 32: 265-267
25. Kotamiemi K (1998) Late onset uveitis in juvenile-type chronic polyarthritis controlled with prednisolone, cyclosporin A and methotrexate. Clin Exp Rheumatol 16: 469-411
26. Kruse FE, Joussen AM, Fotsis T, Schweigerer L, Rohrschneider K, Völcker HE (1997) Diätetische Beeinflussung cornealer Neovaskularisationen am Beispiel der Isoflavonoide. Ophthalmologe 94: 152-156
27. Kruse FE, Joussen AM, Rohrschneider K, Becker MD, Völcker HE (1998) Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefe's Arch Clin Exp Ophthalmol 236: 461-466
28. Lu G, Jun HW, Dzimianski MT, Qiu HC, McCall JW (1995) Pharmacokinetic studies of methotrexate in plasma and synovial fluid following i.v. bolus and topical routes of administration in dogs. Pharm Res 12: 1474-1477
29. Lu G, Jun HW, Suh H (1997) Percutaneous absorbtion and disposition studies of methotrexate in rabbits and rats. Biopharm Drug Dispos 18: 409-422
30. Mizusawa S, Kondoh Y, Murakami M, Nakamichi H, Sasaki H, Komatsu K, Takahashi A, Kudoh Y, Watanabe K, Ono Y (1988) Effect of methotrexate on local cerebral blood flow in conscious rats. Jpn J Pharmacol 48: 499-501
31. Neurath MF, Hildner K, Becker C, Schlaak JF, Barbulescu K, Germann T, Schmitt E, Schirmacher P, Haralambous S, Pasparakis M, Zum Buschenfelde K, Kollias G, Marker-Herrmann E (1999) Methotrexate specifically modulates cytokine produciton by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression. Clin Exp Immunol 115: 42-55
32. Pasi A, Qu B, Messiha FS (1993) Classifying cytostatics on the basis of their angiocidal and angiostatic effects. J Med 24: 289-300
33. Pau HW, Straehler-Pohl HJ, Stiens R (1983) Gefäßschäden durch intraarterielle Gabe von Methotrexat? Laryngol Rhinol Otol (Stuttg) 62: 427-430
34. Sampaio EP, Sarno EN, Galilly R, Chon ZA, Kaplan G (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 173: 699-703
35. Schacht E (1993) Gegenwärtige und zukünftige Therapiestrategien der rheumatoiden Arthritis (RA). Z Rheumatol 52: 365-382
36. Schneider J, Bruckmann W, Zwingenberger K (1997) Extravasation of leukocytes assessed by intravitreal microscopy: effects of thalidomide. Inflamm Res 46: 392-397
37. Shah SS, Lowder CY, Schnitt MA, Wilke WS, Kosmorsky GS, Meisler DM (1992) Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99: 1419-1423
38. Sheu JR, Yen MH, Hung WC, Chang PT, Luk HN (1997) Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v) beta 3 integrin monoclonal antibody. Biochim Biophys Acta 1336: 445-454
39. Singer NG, McCune WJ (1998) Update on immunosuppressive therapy. Curr Opin Rheumatol 10: 169-173
40. Weiss AH, Wallace CA, Sherry DD (1998) Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr 133: 266-268